An advisory panel to the FDA has recommended Johnson & Johnson's experimental nasal spray, which has a compound similar to often-abused ketamine, for patients suffering from depression.


Vladimir Maletic, MD, MS

Psych Congress Steering Committee member Vladimir Maletic, MD, MS, explores the research on the relationship between diet, caloric restriction, and symptoms of depression.

Fathers’ depression during the postnatal period was associated with depression in their daughters 18 years later, researchers found.

Sage Therapeutics Inc's oral treatment for postpartum depression met the main goal of reducing symptoms of the condition, when compared with a placebo in a phase 3 clinical trial.

Teenage girls are twice as likely as boys to show depressive symptoms linked to social media use - mainly due to online harassment and disturbed sleep, as well as poor body image and lower self-esteem, researchers have found.

Anxiety and depression are as predictive of poor physical health as obesity and smoking are and, consequently, should be better addressed during routine visits to primary care providers, suggests a study published online in Health Psychology.



Word on the street is that many physicians do not like undergoing split treatment when they become the patient.

We perpetuate the feeling of being not good enough through slights and microaggressions that we unconsciously inflict upon our peers and colleagues.

Given the high rates of burnout in doctors in this country—and recent research that shows the rates are actually increasing—a telephone call from a colleague in distress is not uncommon.



Roger McIntyre, MD, FRCPC; Dao Thai-Cuarto, PharmD; Joshua Burke, MS; Scott Siegert, PharmD; Dimitri Grigoriadis, PhD
Joseph McEvoy, MD; Benjamin Carroll, PharmD; Sanjay Gandhi, PhD; Avery Rizio, PhD; Stephen Maher, PhD; Mark Kosinski, MA; Jakob Bjorner, MD, PhD
Sanjida Ali, BSc, MBA; Pamela Landsman-Blumberg, MPH DrPH; Marla Kugel, MPH BS; Kenneth Kramer, PhD; Kelly Krogh, PhD
Stewart Factor, DO; Karen Anderson, MD; Mat Davis, PhD; Robert Hauser, MD, MBA; Lars Jarskog, MD; Joohi Jimenez-Shahed, MD; Rajeev Kumar, MD, FRCPC; Stanislaw Ochudlo, MD, PhD; William Ondo, MD; Hubert Fernandez, MD



Psych Congress Steering Committee members Jon W. Draud, MD, MS, and Saundra Jain, MA, PsyD, LPC, discuss some of the practical aspects of setting up a transcranial magnetic stimulation (TMS) chair in a practice.

Psych Congress Steering Committee members Jon W. Draud, MD, MS, and Saundra Jain, MA, PsyD, LPC, discuss the use of transcranial magnetic stimulation (TMS) on patients with treatment-resistant depression.

Gerard Sanacora, MD, PhD, and Charles Raison, MD, talk about considerations surrounding the decision to prescribe ketamine, an experimental therapeutic, to patients struggling with depression.